HCA 241115 365.00P (HCA241115P365000) Stock Options, News & Quotes

US OptionsDetailed Quotes

HCA241115P365000

Watchlist

11.90
-0.88-6.89%

15min DelayClose Oct 30 16:00 ET

11.90High11.90Low

Intraday

5D
Daily

News

Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today
Kevin Travers16:55 ET
Should You Buy, Hold or Sell HCA Healthcare Stock After Q3 Earnings?
Zacks 13:30 ET
Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock
Kevin TraversOct 30 11:59 ET
Call Overwriting and Call Buying Opportunities Within the Russell 1000 – JPM
Seeking AlphaOct 30 09:26 ET
Nasdaq Hits Record High While Wed Earnings Are Mixed | Wall Street Today
Kevin TraversOct 29 17:25 ET
Tuesday Market Falls on Tough Earnings, With AMD and Alphabet Reporting Tonight | Live Stock
Kevin TraversOct 29 11:06 ET

Comments

The Thinker

Oct 25 22:16

Tech Resilience Boosts NASDAQ as Dow and S&P Edge Lower

Click Here: TYNKR LAB™
The U.S. stock market has shown mixed performance in recent sessions, driven by sector-specific gains and losses. As of the latest close, $Dow Jones Industrial Average (.DJI.US)$ experienced a decline of 0.61%, while $S&P 500 Index (.SPX.US)$ slightly edged down by 0.03%. In contrast, $Nasdaq Composite Index (.IXIC.US)$ saw a modest increase of 0.56%, underscoring the continuing resilience of technology stocks even as oth...

Bull X Bear

Oct 16 09:41

Top Picks for US Stocks 🎯

Will Nvidia dethrone Apple as world's most valuable company?

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

Fed officials hawkish: Will inflation roil U.S. bonds?

Analysts Notebook

Sep 5 06:06

Columns 'Trump Trade' vs. 'Harris Trade': How They Could Shape Your Portfolio

The 2024 U.S. presidential race between former President Donald Trump and current Vice President Kamala Harris is still "incredibly close," according to the latest New York Times survey. As investors await the outcome of the November election, equity analysts are busy parsing through the candidates' pronouncements for clues on which stocks could benefit from their policies.
Jefferies analysts cited 10 possible policies that Tr...

Countdown to the election! How will you strategize in the final week?

Analysts Notebook

Aug 27 06:33

Columns Ready for Fed Rate Cuts? Biotech's Potential to Watch

The Federal Reserve appears poised to cut interest rates later this year. While the broader stock market might breathe a sigh of relief, certain sectors could be more significantly impacted than others. Biotechnology could be one of those sectors - at least, that's what Morgan Stanley believes.
In 2024, biotech stocks had a slow start, with the S&P Biotechnology Select Industry Index returning just under 4% in the first six months, compared to...

Fed officials hawkish: Will inflation roil U.S. bonds?